MEDINDIA
English
हिन्दी
Español
français
中文
The Nuvaxovid vaccine for COVID-19 has been approved by the French National Authority of Health. Nuvaxovid, manufactured by American biotechnology company Novavax, is suitable for people over the age of 18, with a delay between doses of three weeks.
TOP INSIGHT
The five COVID-19 vaccines authorized in France are Pfizer/BioNTech, Moderna, AstraZeneca, Janssen and Nuvaxovid.
The health authority said the Novaxovid vaccine can be used for those who have not received any shots, or cannot receive the mRNA vaccines.
The Ministry of Health has said that the first injections of Nuvaxovid can start in February, and it will receive 3.2 million doses for the first trimester.
COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.
Source-IANS
Tuberculosis Vaccine may Assist Future COVID-19 Vaccine Development
Research findings suggest a strategy to ‘complement and extend’ the protection offered by existing COVID-19 vaccines.
Research findings suggest a strategy to ‘complement and extend’ the protection offered by existing COVID-19 vaccines.
Email
